Cancer vaccination at older age

Interdisciplinary Topics in Gerontology

Volumn 38, Issue , 2013, Pages 28-37

  Gravekamp, Claudia ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ADAPTIVE IMMUNITY; AGE; AGED; AGING; ANIMAL; ARTICLE; CARCINOGENESIS; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG SCREENING; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INNATE IMMUNITY; METABOLISM; METHODOLOGY; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEOPLASM; SYSTEMS BIOLOGY; TUMOR MICROENVIRONMENT;

ADAPTIVE IMMUNITY; AGE FACTORS; AGED; AGING; ANIMALS; CANCER VACCINES; CARCINOGENESIS; DRUG EVALUATION; DRUG EVALUATION, PRECLINICAL; HUMANS; IMMUNITY, INNATE; IMMUNOTHERAPY; KILLER CELLS, NATURAL; MICE; NATURAL KILLER T-CELLS; NEOPLASMS; SYSTEMS BIOLOGY; T-LYMPHOCYTES, CYTOTOXIC; TUMOR MICROENVIRONMENT;

EID: 84925759405     PISSN: 00741132     EISSN: 16623800     Source Type: Book Series    
DOI: 10.1159/000343596     Document Type: Article

References (48)

1. Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009;27: 2758-2765.
2. Jemal A, Murray T, Ward E, et al: Cancer statistics. CA Cancer J Clin 2005;55: 10-30.
3. Castro F, Leal B, Denny A, et al: Vaccination with Mage- b DNA induces CD8 T cell responses at young but not at old age in mice with metastatic breast cancer. Br J Cancer 2009;101: 1329-1337.
4. Gravekamp C: The importance of the age factor in cancer vaccination at older age. Cancer Immunol Immunother 2009;58: 1969-1977.
5. Utsuyama M, Hirokawa K, Kurashima C: Differential age change in the number of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev 1992;63: 57-68.
6. Tamir A, Eisenbraun MD, Garcia GG: Agedependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J Immunol 2000;165: 1243-1251.
7. Wack A, Cossarizza A, Heltai S: Age- related modifications of the human αβ T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. Int Immunol 1998;10: 1281-1288.
8. Effros RB: Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 2006;7: 599-604.
9. McElhaney JE, Meneilly GS, Lechelt KE, Bleackley RC: Split- virus influenza vaccines: do they provide adequate immunity in the elderly? J Gerontol 1994; 4:M37-M43.
10. Gomez CR, Nomelli V, Faunce DE, Kovacs EJ: Innate immunity and aging. Exp Gerontol 2008;43: 718-728.
11. Ogata K, Yokose N, Tamura H, et al: Natural killer cells in the late decades of human life. Clin Immunol Immunopathol 1997;84: 269-275.
12. Mocchegiani E, Malavolta M: NK and NKT cell functions in immunosenescence. Aging Cell 2004;3: 177-184.
13. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ: Aging and innate immune cells. J Leukoc Biol 2004; 76: 291-199.
14. Biron CA, Brossay L: NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001;13: 458-464.
15. Re F, Donnini A, Bartozzi B, et al: Circulating γδT cells in young/adult and old patients with cutaneous primary melanoma. Immun Ageing 2005;2:2.
16. Argentati K, Re F, Donnini A, et al: Numerical and functional alterations of circulating γδT lymphocytes in aged people and centenarians. J Leukoc Biol 2002;72: 65-71.
17. Sauerwein- Teissl M, Schonitzer D, Grubeck- Loebenstin B: Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age. Exp Gerontol 1998;33: 625-631.
18. Sprecher E, Becker Y, Kraal G: Effect of aging on the epidermal dendritic cell population in C57Bl/6J mice. J Invest Dermatol 1990;94: 247-253.
19. Bella D, Bierti L, Presicce P: Peripheral blood dendritic cells and monocytes are differentially regulated in the elderly. Clin Immunol 2007;122: 220-228.
20. Agrawal A, Agrawal S, Cao JN: Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3- kinase- signaling pathway. J Immunol 2007;178: 6912-6922.
21. Gravekamp C, Bontenbal M, Ronteltap C: In vitro and in vivo activation of CD4+ lymphocytes by autologous tumor cells. Int J Cancer 1990;46: 152-154.
22. Gabrilovich DI, Nagaraj S: Myeloid- derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9: 162-174.
23. Sica A, Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007;117: 1155-1166.
24. Grizzle WE, Xy X, Zhang S, et al: Age- related increase of tumor susceptibility is associated with myeloid- derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev 2007;128: 672-680.
25. Shimizu J, Yamzaki S, Sakaguchi S: Induction of tumor immunity by removing CD4+CD25+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999;163: 5211-5218.
26. Gregg R, Smith CM, Clark FJ, et al: The number of human peripheral blood CD4+CD25high regulatory T cells increases with age. Clin Exp Immunol 2005; 140: 540-546.
27. Guerra N, Tan YX, Joncker NT, et al: NKG2Ddefiecient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008;28: 571-580.
28. Mocikat R, Braumuller H, Gumy A: Natural killer cells activated by MHC class Il targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 2003;19: 561-569.
29. Hallett WHD, Ames E, Motarjemi M, et al: Sensitization of tumor cells to NK cell- mediated killing by proteosome inhibition. J Immunol 2008;180: 163-170.
30. Nakui M, Ohta A, Sekimoto M, et al: Potentiation of antitumor effect of NKT cell ligand α- galactosylceramide by combination with IL- 12 on lung metastasis of malignant melanoma cells. Clin Exp Metastasis 2000;18: 147-153.
31. Nakagawa R, Serizawa I, Motoki K, et al: Antitumor activity of α- galactosylceramide, KRN7000, in mice with melanoma B16 hepatic metastases and immunological study of tumor- infiltrating cells. Oncol Res 2000;12: 51-58.
32. Giaccone G, Punt CJ, Ando Y, et al: A phase I study of natural killer T ligand α- galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002;8: 3702-3709.
33. Wilhelm M, Kunzman V, Eckstein S, et al: γδT cells for immune therapy of patients with lymphoid malignancies. Blood 2003;102: 200-206.
34. Provinciali M, Argentati K, Tibaldi A: Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL- 2 are rejected but do not induce tumor- specific immune memory in old mice. Gene Ther 2000;7: 624-632.
35. Provinciali M, Smorlesi A, Donnini A: Low effectiveness of DNA vaccination against HER2/neu in aging. Vaccine 2003;21: 843-848.
36. Provinciali M, Barucca A, Pierpaoli E, et al: In vivo electroporation restores low effectiveness of DNA vaccination against HER2/neu in aging. CII 2012; 61: 363-371.
37. Lustgarten J, Dominguez AL, Thomas M: Aged mice develop protective anti- tumor responses with appropriate costimulation. J Immunol 2004;173: 4510-4515.
38. Sharma S, Domiguez AL, Lustgarten J: Aging affect the anti- tumor potential of dendritic cell vaccination, but it can be overcome by co- stimulation with anti- OX40 or anti- 4- 1BB. Exp Gerontol 2006;41: 78-84.
39. Grolleau- Julius A, Abernathy L, Harning E, Yung RL: Mechanisms of murine dendritic cell antitumor dysfunction in aging. Cancer Immunol Immunother 2009;58: 1935-1939.
40. Kim SH, Castro F, Paterson Y, Gravekamp C: High efficacy of a Listeria- based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Res 2009;69: 5860-5866.
41. Jouen- Bades F, Paris E, Dieulois C, et al: In vivo and in vitro activation and expansion of γδT cells during Listeria monocytogenes infection in humans. Infect Immun 1997;65: 4267-4272.
42. Lechner MG, Epstein AL: A new mechanism for blocking myeloid- derived suppressor cells by CpG. Clin Cancer Res 2011;17: 1645-1648.
43. Tu SP, Jin H, Shi JD, et al: Curcumin induces the differentiation of myeloid- derived suppressor cells and inhibits their interaction with cancer cells and related tumor growth. Cancer Prev Res (Phila) 2012;5: 205-215.
44. Maletto B, Ropolo A, Moron V, Pistoresi- Palencia MC: CpG- DNA stimulates cellular and humoral immunity and promotes TH1 differentiation in aged BALB/C mice. J Leukoc Biol 2002;72: 447-454.
45. Stacy S, Infante AJ, Wall K: Recall immune memory: a new tool for generating late onset autoimmune myasthenia gravis. Mech Ageing Dev 2003; 124: 931-940.
46. Tan JT, Dudl E, LeRoy E: IL- 7 is critical for homeostatic proliferation and survival of naïve T cells. Proc Natl Acad Sci USA 2001;98: 8732-8737.
47. Patyar S, Joshi R, Byrav DS, Prakash A, Medhi B, Das BK: Bacteria in cancer therapy: a novel experimental strategy. J Biomed Sci 2010;17:21.
48. Stanley SA, Gagner JE, Damanpour S, et al: Radiowave heating of iron oxide nanoparticles can regulate plasma glucose in mice. Science 2012;336: 604-608.